Total Payments
$1,919
2024 Payments
$404.49
Companies
10
Transactions
39
Medicare Patients
10,889
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$1,919 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,919 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $739.65 | 11 | $0 (2024) |
| Amgen Inc. | $429.69 | 3 | $0 (2018) |
| Regeneron Pharmaceuticals, Inc. | $262.83 | 2 | $0 (2019) |
| AbbVie Inc. | $177.99 | 8 | $0 (2023) |
| Merck Sharp & Dohme LLC | $116.08 | 6 | $0 (2024) |
| Lilly USA, LLC | $81.14 | 4 | $0 (2024) |
| SHIELD THERAPEUTICS INC | $49.65 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $22.91 | 1 | $0 (2024) |
| PFIZER INC. | $20.51 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $18.13 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $404.49 | 14 | AstraZeneca Pharmaceuticals LP ($249.79) |
| 2023 | $213.99 | 10 | AbbVie Inc. ($115.25) |
| 2022 | $99.06 | 5 | ABBVIE INC. ($44.08) |
| 2021 | $18.66 | 1 | AbbVie Inc. ($18.66) |
| 2019 | $133.23 | 1 | Regeneron Pharmaceuticals, Inc. ($133.23) |
| 2018 | $254.60 | 2 | Regeneron Pharmaceuticals, Inc. ($129.60) |
| 2017 | $794.55 | 6 | AstraZeneca Pharmaceuticals LP ($489.86) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Hematology | ||||||
| 09/16/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.13 | General |
| Category: Cardiovascular | ||||||
| 06/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: RESPIRATORY | ||||||
| 06/03/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Hematology | ||||||
| 04/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Respiratory | ||||||
| 03/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Diabetes | ||||||
| 03/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $120.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Respiratory | ||||||
| 01/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/04/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/19/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO, BELSOMRA | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/25/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Diabetes | ||||||
| 08/17/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/27/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, STEGLATRO | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 2,478 | 4,539 | $808,152 | $349,415 |
| 2022 | 35 | 2,378 | 4,333 | $734,866 | $325,115 |
| 2021 | 41 | 2,956 | 5,349 | $808,090 | $410,629 |
| 2020 | 38 | 3,077 | 5,195 | $682,749 | $367,491 |
Total Patients
10,889
Total Services
19,416
Medicare Billing
$1.5M
Procedure Codes
153
All Medicare Procedures & Services
153 procedure records from CMS Medicare Utilization — Page 2 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 102 | $3,060 | $1,319 | 43.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 44 | 44 | $1,320 | $1,294 | 98.0% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 12 | 12 | $1,860 | $1,273 | 68.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 88 | 95 | $2,375 | $1,253 | 52.8% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 12 | 12 | $2,160 | $1,218 | 56.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 19 | $3,595 | $889.64 | 24.7% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 19 | 21 | $1,470 | $875.62 | 59.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 15 | 15 | $1,050 | $816.54 | 77.8% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2023 | 15 | 22 | $1,100 | $717.42 | 65.2% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 31 | 31 | $775.00 | $634.26 | 81.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 15 | 15 | $900.00 | $544.83 | 60.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 19 | 19 | $1,615 | $525.84 | 32.6% |
| 92567 | Test to assess middle ear function | Office | 2023 | 32 | 32 | $960.00 | $436.52 | 45.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 13 | 13 | $650.00 | $279.84 | 43.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 301 | 1,075 | $161,250 | $81,719 | 50.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 279 | 882 | $132,100 | $71,189 | 53.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 196 | 196 | $35,280 | $30,726 | 87.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 234 | $42,120 | $25,599 | 60.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 101 | 101 | $30,300 | $19,131 | 63.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 124 | 270 | $139,711 | $18,145 | 13.0% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 126 | 127 | $15,875 | $9,911 | 62.4% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 46 | 47 | $16,450 | $8,997 | 54.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 33 | 33 | $9,900 | $6,408 | 64.7% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 33 | 33 | $9,240 | $5,897 | 63.8% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 38 | 38 | $6,650 | $4,748 | 71.4% |
About Dr. Leonid Volfinzon, M.D
Dr. Leonid Volfinzon, M.D is a Internal Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952403933.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonid Volfinzon, M.D has received a total of $1,919 in payments from pharmaceutical and medical device companies, with $404.49 received in 2024. These payments were reported across 39 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,919).
As a Medicare-enrolled provider, Volfinzon has provided services to 10,889 Medicare beneficiaries, totaling 19,416 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 153 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Brooklyn, NY
- Active Since 09/01/2006
- Last Updated 03/19/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952403933
Products in Payments
- BEVESPI AEROSPHERE (Drug) $489.86
- Repatha (Biological) $243.06
- FARXIGA (Drug) $204.76
- Prolia (Biological) $186.63
- UBRELVY (Drug) $149.11
- DUPIXENT (Biological) $133.23
- DUPIXENT DUPILUMAB INJECTION (Biological) $129.60
- MOUNJARO (Drug) $57.14
- BELSOMRA (Drug) $54.76
- ACCRUFER (Drug) $49.65
- BREZTRI (Drug) $45.03
- QULIPTA (Drug) $28.88
- LAGEVRIO (Drug) $25.18
- TRELEGY ELLIPTA (Drug) $22.91
- VERQUVO (Drug) $21.79
- PAXLOVID (Drug) $20.51
- CAMZYOS (Drug) $18.13
- STEGLATRO (Drug) $14.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brooklyn
Bruce Berger, M.d, M.D
Internal Medicine — Payments: $3.0M
Internal Medicine $3.0M
Dr. Jesi Ramone, Md, MD
Internal Medicine — Payments: $701,491
Internal Medicine $701,491
Dr. Ali El Atat, M.d, M.D
Internal Medicine — Payments: $426,309
Internal Medicine $426,309
Manish Parikh, Md, MD
Internal Medicine — Payments: $360,332
Internal Medicine $360,332
Dr. Samuel Uter, Md, MD
Internal Medicine — Payments: $238,375
Internal Medicine $238,375
Dr. Bharath Reddy, Md, MD
Internal Medicine — Payments: $159,733
Internal Medicine $159,733